Related Experiment Video

Updated: Aug 15, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

Protective effect of left ventricular hypertrophy in right coronary artery occlusions

M de F Gomes1, C A Gottschall

  • 1Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre, Brazil.

Arquivos Brasileiros De Cardiologia
|September 17, 1999
PubMed

Insights

Left ventricular hypertrophy (LVH) significantly reduces heart damage and preserves left ventricular function following right coronary artery occlusion. This protective effect was observed in patients with LVH compared to those without.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Medical Science

Background:

  • Left ventricular hypertrophy (LVH) is a condition where the left ventricle wall thickens.
  • The impact of LVH on the consequences of right coronary artery occlusion requires further investigation.

Purpose of the Study:

  • To determine if left ventricular hypertrophy (LVH) mitigates the electrocardiographic and functional impacts of right coronary artery occlusion.
  • To compare the outcomes of right coronary artery occlusion in patients with and without LVH.

Main Methods:

  • Analysis of 215 patients with right coronary artery occlusion and no other significant coronary lesions.
  • Patients were categorized into two groups: Group A (78 patients) with LVH (left ventricular mass > 100 g/m2) and Group B (137 patients) without LVH (left ventricular mass < 100 g/m2).
  • Demographic data (age, gender) showed no significant differences between groups.

Main Results:

  • Group A (with LVH) exhibited significantly less transmural necrosis (30.8% vs. 56.9%, p < 0.05) compared to Group B.
  • Left ventricular function parameters were superior in Group A, including lower end-diastolic pressure/systolic pressure ratio, lower end-diastolic and end-systolic volume indices, higher ejection fraction, and better anteroinferior shortening (all p < 0.05).
  • Group A also showed increased coronary tortuosity (78.2% vs. 24.1%, p < 0.001) and a higher frequency of absent or minimal diaphragmatic hypokinesis (80.8% vs. 54.0%, p < 0.05).

Conclusions:

  • Left ventricular hypertrophy (LVH) demonstrates a protective role against myocardial sequelae following right coronary artery occlusion.
  • LVH appears to preserve left ventricular function in the context of right coronary artery occlusion.
Abstract

More Related Videos

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice10:18

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...